Nathalie Quénel-Tueux

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1

Filippo Montemurro, Antonio Antón, Rachel Wuerstlein et al. · European Journal of Cancer · 2019 · 102 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinical Practice Guidelines for the Management of Patients With Endometrial Cancer in France

Denis Querleu, François Planchamp, Fabrice Narducci et al. · International Journal of Gynecological Cancer · 2011 · 99 citations

Medicine, Oncology, Surgery +13

Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study

Hervé Bonnefoi, William Jacot, Mahasti Saghatchian et al. · Annals of Oncology · 2014 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)

Domitille Dano, Audrey Lardy-Cléaud, Audrey Monneur et al. · ESMO Open · 2021 · 37 citations · Full text

Medicine, Oncology, Breast Oncology +12

Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre

Pierre-Antoine Linck, Cassandre Garnier, Marie-Pierre Depetiteville et al. · European Radiology · 2021 · 33 citations · Full text

Medicine, Oncology, Surgery +8